GoldPoint Clinical Research is The Midwest’s Leading Clinical Trial Research Site for Central Nervous System Disorders and General Medical Disorders
GoldPoint Clinical Research is one of Indianapolis’ leading clinical research centers for central nervous system (CNS) disorders, specializing in psychological, mental health and neurological conditions. The private research facility works with some of the world’s largest pharmaceutical companies and life science contract research organizations (CROs) to conduct Phase II, III & IV clinical trials for alcoholism and drug addiction, Alzheimer’s disease and dementia, generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), autism, bipolar disorder, depression, fibromyalgia, insomnia, obsessive compulsive disorder (OCD), panic disorder, post traumatic stress disorder (PTSD), schizophrenia, social anxiety disorder (social phobia) and others.
Collectively, GoldPoint’s primary staff has conducted more than 250 neuroscience research studies. The company specializes in effective patient recruitment, careful diagnosis of mental health disorders, testing innovative drug treatments and collecting quality data to assist in bringing new scientific breakthroughs to market.